Status:
COMPLETED
Development and Validation of a Patient Reported Experience Measure for Experimental Cancer Medicine
Lead Sponsor:
The Christie NHS Foundation Trust
Conditions:
Cancer
Eligibility:
All Genders
18+ years
Brief Summary
This is a four stage, non-interventional study to develop and pilot test a Patient Reported Experience Measure (PREM) in experimental cancer medicine trials.
Detailed Description
PREM-ECM will be conducted in four stages Stage I - Item generation Two focus groups with four-eight participants each and approximately 20 interviews will be conducted with experimental cancer medic...
Eligibility Criteria
Inclusion
- Patient
- Recruited into a phase 1-2 experimental cancer medicine clinical trial
- Ability to understand and communicate in the English language
- Able to provide written informed consent
- Patient
Exclusion
- Patients who are not able to complete informed consent or the study questionnaires
- Carer Inclusion Criteria:
- Ability to understand and communicate in the English language
- Able to provide written informed consent
- Nominated by the patient as their primary caregiver/most able to describe relevant experience
- Carer
Key Trial Info
Start Date :
July 16 2018
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
November 20 2023
Estimated Enrollment :
570 Patients enrolled
Trial Details
Trial ID
NCT05386602
Start Date
July 16 2018
End Date
November 20 2023
Last Update
October 4 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
The Christie NHS Foundation Trust
Manchester, Greater Manchester, United Kingdom, M20 4BX